RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Ricardo Richardson to Humans

This is a "connection" page, showing publications Ricardo Richardson has written about Humans.
Connection Strength

0.262
  1. Adekoya TO, Smith N, Thomas AJ, Lane TS, Burnette N, Rivers EJ, Li Y, Chen XL, Richardson RM. Host versus cell-dependent effects of ?-arrestin 1 expression in prostate tumorigenesis. Carcinogenesis. 2021 05 28; 42(5):772-783.
    View in: PubMed
    Score: 0.039
  2. Adekoya TO, Richardson RM. Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis. Int J Mol Sci. 2020 Jun 23; 21(12).
    View in: PubMed
    Score: 0.037
  3. Adekoya TO, Smith N, Aladeniyi T, Blumer JB, Chen XL, Richardson RM. Activator of G protein signaling 3 modulates prostate tumor development and progression. Carcinogenesis. 2019 12 31; 40(12):1504-1513.
    View in: PubMed
    Score: 0.035
  4. Singh V, Raghuwanshi SK, Smith N, Rivers EJ, Richardson RM. G Protein-coupled receptor kinase-6 interacts with activator of G protein signaling-3 to regulate CXCR2-mediated cellular functions. J Immunol. 2014 Mar 01; 192(5):2186-94.
    View in: PubMed
    Score: 0.023
  5. Raghuwanshi SK, Su Y, Singh V, Haynes K, Richmond A, Richardson RM. The chemokine receptors CXCR1 and CXCR2 couple to distinct G protein-coupled receptor kinases to mediate and regulate leukocyte functions. J Immunol. 2012 Sep 15; 189(6):2824-32.
    View in: PubMed
    Score: 0.021
  6. Nasser MW, Raghuwanshi SK, Grant DJ, Jala VR, Rajarathnam K, Richardson RM. Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer. J Immunol. 2009 Sep 01; 183(5):3425-32.
    View in: PubMed
    Score: 0.017
  7. Nasser MW, Raghuwanshi SK, Malloy KM, Gangavarapu P, Shim JY, Rajarathnam K, Richardson RM. CXCR1 and CXCR2 activation and regulation. Role of aspartate 199 of the second extracellular loop of CXCR2 in CXCL8-mediated rapid receptor internalization. J Biol Chem. 2007 Mar 02; 282(9):6906-15.
    View in: PubMed
    Score: 0.014
  8. Nasser MW, Marjoram RJ, Brown SL, Richardson RM. Cross-desensitization among CXCR1, CXCR2, and CCR5: role of protein kinase C-epsilon. J Immunol. 2005 Jun 01; 174(11):6927-33.
    View in: PubMed
    Score: 0.013
  9. Richardson RM, Tokunaga K, Marjoram R, Sata T, Snyderman R. Interleukin-8-mediated heterologous receptor internalization provides resistance to HIV-1 infectivity. Role of signal strength and receptor desensitization. J Biol Chem. 2003 May 02; 278(18):15867-73.
    View in: PubMed
    Score: 0.011
  10. Rajarathnam K, Schnoor M, Richardson RM, Rajagopal S. How do chemokines navigate neutrophils to the target site: Dissecting the structural mechanisms and signaling pathways. Cell Signal. 2019 02; 54:69-80.
    View in: PubMed
    Score: 0.008
  11. Spruiell K, Gyamfi AA, Yeyeodu ST, Richardson RM, Gonzalez FJ, Gyamfi MA. Pregnane X Receptor-Humanized Mice Recapitulate Gender Differences in Ethanol Metabolism but Not Hepatotoxicity. J Pharmacol Exp Ther. 2015 Sep; 354(3):459-70.
    View in: PubMed
    Score: 0.006
  12. Spruiell K, Richardson RM, Cullen JM, Awumey EM, Gonzalez FJ, Gyamfi MA. Role of pregnane X receptor in obesity and glucose homeostasis in male mice. J Biol Chem. 2014 Feb 07; 289(6):3244-61.
    View in: PubMed
    Score: 0.006
  13. Vidal AC, Tucker C, Schildkraut JM, Richardson RM, McPhail M, Freedland SJ, Hoyo C, Grant DJ. Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study. BMC Cancer. 2013 Nov 22; 13:556.
    View in: PubMed
    Score: 0.006
  14. Grant DJ, Hoyo C, Oliver SD, Gerber L, Shuler K, Calloway E, Gaines AR, McPhail M, Livingston JN, Richardson RM, Schildkraut JM, Freedland SJ. Association of uridine diphosphate-glucuronosyltransferase 2B gene variants with serum glucuronide levels and prostate cancer risk. Genet Test Mol Biomarkers. 2013 Jan; 17(1):3-9.
    View in: PubMed
    Score: 0.005
  15. Toda M, Kuo CH, Borman SK, Richardson RM, Inoko A, Inagaki M, Collins A, Schneider K, Ono SJ. Evidence that formation of vimentin mitogen-activated protein kinase (MAPK) complex mediates mast cell activation following FceRI/CC chemokine receptor 1 cross-talk. J Biol Chem. 2012 Jul 13; 287(29):24516-24.
    View in: PubMed
    Score: 0.005
  16. Livingston JN, Smith NP, Mills C, Singleton DM, Dacons-Brock K, Richardson R, Grant D, Craft H, Harewood K. Theater as a tool to educate African Americans about breast cancer. J Cancer Educ. 2009; 24(4):297-300.
    View in: PubMed
    Score: 0.004
  17. Beer F, Kuo CH, Morohoshi K, Goodliffe J, Munro P, Aye CC, Dawson M, Richardson RM, Jones LH, Ikeda Y, Nakamura T, Toda M, Flynn T, Ohbayashi M, Miyazaki D, Ono SJ. Role of beta-chemokines in mast cell activation and type I hypersensitivity reactions in the conjunctiva: in vivo and in vitro studies. Immunol Rev. 2007 Jun; 217:96-104.
    View in: PubMed
    Score: 0.004
  18. Toda M, Nakamura T, Ohbayashi M, Ikeda Y, Dawson M, Richardson RM, Alban A, Leed B, Miyazaki D, Ono SJ. Role of CC chemokines and their receptors in multiple aspects of mast cell biology: comparative protein profiling of FcepsilonRI- and/or CCR1-engaged mast cells using protein chip technology. Novartis Found Symp. 2005; 271:131-40; discussion 140-51.
    View in: PubMed
    Score: 0.003
  19. Toda M, Dawson M, Nakamura T, Munro PM, Richardson RM, Bailly M, Ono SJ. Impact of engagement of FcepsilonRI and CC chemokine receptor 1 on mast cell activation and motility. J Biol Chem. 2004 Nov 12; 279(46):48443-8.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support